RECRUITING

Cardiac Outcomes With Near-Complete Estrogen Deprivation

Description

The purpose of this research study is to understand what effect near complete estrogen deprivation (NCED) therapy has on the heart in breast cancer patients. Investigators want to understand if NCED changes how the heart works.

Study Overview

Study Details

Study overview

The purpose of this research study is to understand what effect near complete estrogen deprivation (NCED) therapy has on the heart in breast cancer patients. Investigators want to understand if NCED changes how the heart works.

The Cardiac Outcomes With Near-Complete Estrogen Deprivation (CROWN) Study

Cardiac Outcomes With Near-Complete Estrogen Deprivation

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Durham

Duke Cancer Center, Durham, North Carolina, United States, 27710

Winston-Salem

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States, 27157

Richmond

Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States, 23298

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * History of allergic reactions attributed to compounds of similar chemical or biologic composition to adenosine
  • * Active wheezing.
  • * Those with contraindications for MRI such as ferromagnetic cerebral aneurysm clips or other intracranial metal, pacemakers, defibrillators, functioning neurostimulator devices or other implanted electronic devices, or some breast expanders.
  • * Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
  • * Pregnant women are excluded from this study. Because some methods of birth control are not 100% reliable, a pregnancy test is required, unless the patient has undergone either a bilateral oophorectomy, hysterectomy or both.
  • * Coronary revascularization in the past 6 months or known severe multi-vessel coronary artery disease previously determined to be not amendable to mechanical intervention.
  • * Ongoing, unrelieved symptoms thought to represent cardiac ischemia and requiring immediate cardiac catheterization
  • * Allergy or prior sensitivity to gadolinium or other contrasting agents or their excipients.
  • * Men with breast cancer.
  • * Known chronic renal insufficiency or chronic electrolyte abnormalities as determined by the treating physician.

Ages Eligible for Study

18 Years to 55 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Wake Forest University Health Sciences,

Alexandra Thomas, MD, PRINCIPAL_INVESTIGATOR, Wake Forest Baptist Comprehensive Cancer Center

Study Record Dates

2027-12